235 related articles for article (PubMed ID: 15993357)
21. [Renal function in diabetic children and adolescents. Relation to the duration and level of control of the disease].
Blasco González L; López García MJ; Alpera la Cruz R; Plasencia Cochoud A; García Ballester M; Carbonell Sales MJ
An Esp Pediatr; 1992 Jun; 36(6):460-6. PubMed ID: 1497228
[TBL] [Abstract][Full Text] [Related]
22. Diabetic nephropathy. A clinical study of risk factors in type-I diabetes mellitus.
Nordén G
Scand J Urol Nephrol Suppl; 1988; 116():1-76. PubMed ID: 3227321
[TBL] [Abstract][Full Text] [Related]
23. Nephelometry in the clinical assessment of glomerular proteinuria and tubular function in diabetic nephropathy.
Solerte SB; Severgnini S; Locatelli M; Cerutti N; Rondanelli M; Netti MA; Ferrari E; Fioravanti M
Clin Nephrol; 1997 Sep; 48(3):151-8. PubMed ID: 9342486
[TBL] [Abstract][Full Text] [Related]
24. Familial factors in diabetic nephropathy: an offspring study.
Agius E; Attard G; Shakespeare L; Clark P; Vidya MA; Hattersley AT; Fava S
Diabet Med; 2006 Mar; 23(3):331-4. PubMed ID: 16492220
[TBL] [Abstract][Full Text] [Related]
25. [Microalbuminuria--a risk indicator for the development of nephropathy in insulin-dependent diabetics].
Dryáková M; Englis M; Bartos V; Rozprimová L; Sidlová A; Malý J
Cas Lek Cesk; 1989 Oct; 128(43-44):1372-6. PubMed ID: 2598252
[TBL] [Abstract][Full Text] [Related]
26. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy.
Katavetin P; Eiam-Ong S; Suwanwalaikorn S
J Med Assoc Thai; 2006 Feb; 89(2):170-7. PubMed ID: 16579002
[TBL] [Abstract][Full Text] [Related]
27. [Qualitative study of proteinuria in diabetic nephropathy].
Faure Nogueras E; Blasco Comenge MC; Guillén Martínez G
An Med Interna; 1991 Jul; 8(7):333-5. PubMed ID: 1932490
[TBL] [Abstract][Full Text] [Related]
28. Effects of aerobic exercise on microalbuminuria and enzymuria in type 2 diabetic patients.
Lazarevic G; Antic S; Vlahovic P; Djordjevic V; Zvezdanovic L; Stefanovic V
Ren Fail; 2007; 29(2):199-205. PubMed ID: 17365936
[TBL] [Abstract][Full Text] [Related]
29. Diabetic nephropathy in 27,805 children, adolescents, and adults with type 1 diabetes: effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex.
Raile K; Galler A; Hofer S; Herbst A; Dunstheimer D; Busch P; Holl RW
Diabetes Care; 2007 Oct; 30(10):2523-8. PubMed ID: 17630266
[TBL] [Abstract][Full Text] [Related]
30. Urinary excretion of 8-oxo-7, 8-dihydro-2'-deoxyguanosine as a predictor of the development of diabetic nephropathy.
Hinokio Y; Suzuki S; Hirai M; Suzuki C; Suzuki M; Toyota T
Diabetologia; 2002 Jun; 45(6):877-82. PubMed ID: 12107732
[TBL] [Abstract][Full Text] [Related]
31. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.
Saraheimo M; Forsblom C; Thorn L; Wadén J; Rosengård-Bärlund M; Heikkilä O; Hietala K; Gordin D; Frystyk J; Flyvbjerg A; Groop PH;
Diabetes Care; 2008 Jun; 31(6):1165-9. PubMed ID: 18346990
[TBL] [Abstract][Full Text] [Related]
32. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
Navarro JF; Mora C; Gómez M; Muros M; López-Aguilar C; García J
Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
[TBL] [Abstract][Full Text] [Related]
33. Increased urinary excretion of orosomucoid is a risk predictor of diabetic nephropathy.
Jiang H; Guan G; Zhang R; Liu G; Liu H; Hou X; Cheng J
Nephrology (Carlton); 2009 Apr; 14(3):332-7. PubMed ID: 19143942
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for development and progression of diabetic kidney disease and treatment patterns among diabetic siblings of patients with diabetic kidney disease.
Bleyer AJ; Sedor JR; Freedman BI; O'Brien A; Russell GB; Graley J; Schelling JR
Am J Kidney Dis; 2008 Jan; 51(1):29-37. PubMed ID: 18155530
[TBL] [Abstract][Full Text] [Related]
35. Pregnancy-associated plasma protein A in a large cohort of Type 1 diabetic patients with and without diabetic nephropathy-a prospective follow--up study.
Astrup AS; Tarnow L; Christiansen M; Hansen PR; Parving HH; Rossing P
Diabet Med; 2007 Dec; 24(12):1381-5. PubMed ID: 17971180
[TBL] [Abstract][Full Text] [Related]
36. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus.
Agha A; Bashir K; Anwar E
Nepal Med Coll J; 2007 Jun; 9(2):79-83. PubMed ID: 17899953
[TBL] [Abstract][Full Text] [Related]
37. Thailand diabetes registry project: prevalence, characteristics and treatment of patients with diabetic nephropathy.
Ngarmukos C; Bunnag P; Kosachunhanun N; Krittiyawong S; Leelawatana R; Prathipanawatr T; Plengvidhya N; Benjasuratwong Y; Suwanwalaikorn S; Deerochanawong C; Chetthakul T; Mongkolsomlit S; Rawdaree P
J Med Assoc Thai; 2006 Aug; 89 Suppl 1():S37-42. PubMed ID: 17715832
[TBL] [Abstract][Full Text] [Related]
38. Serum cystatin C in diabetic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy.
Ogawa Y; Goto T; Tamasawa N; Matsui J; Tando Y; Sugimoto K; Tomotsune K; Kimura M; Yasujima M; Suda T
Diabetes Res Clin Pract; 2008 Feb; 79(2):357-61. PubMed ID: 17980929
[TBL] [Abstract][Full Text] [Related]
39. Urinary excretions of lipocalin-type prostaglandin D2 synthase predict the development of proteinuria and renal injury in OLETF rats.
Ogawa M; Hirawa N; Tsuchida T; Eguchi N; Kawabata Y; Numabe A; Negoro H; Hakamada-Taguchi R; Seiki K; Umemura S; Urade Y; Uehara Y
Nephrol Dial Transplant; 2006 Apr; 21(4):924-34. PubMed ID: 16384826
[TBL] [Abstract][Full Text] [Related]
40. Effect of high dose thiamine on the levels of urinary protein biomarkers in diabetes mellitus type 2.
Riaz S; Skinner V; Srai SK
J Pharm Biomed Anal; 2011 Mar; 54(4):817-25. PubMed ID: 21130593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
